Cargando…
Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor
Primary carcinoid tumor of the kidney is an extremely rare well-differentiated neuroendocrine tumor, which is generally a low-grade malignant cancer with a good prognosis. Carcinoid tumors are rarely found in the urinary system. Here, we report a 34-year-old woman with primary renal well-differentia...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153994/ https://www.ncbi.nlm.nih.gov/pubmed/35655605 http://dx.doi.org/10.2147/OTT.S364545 |
_version_ | 1784717948104998912 |
---|---|
author | Jiang, Hua Zhang, He |
author_facet | Jiang, Hua Zhang, He |
author_sort | Jiang, Hua |
collection | PubMed |
description | Primary carcinoid tumor of the kidney is an extremely rare well-differentiated neuroendocrine tumor, which is generally a low-grade malignant cancer with a good prognosis. Carcinoid tumors are rarely found in the urinary system. Here, we report a 34-year-old woman with primary renal well-differentiated neuroendocrine tumor who underwent nephron sparing surgery and no evidence of recurrence or distant metastasis was found during routine follow-up. We searched the case of renal carcinoid with the search phrase “carcinoid [title] and kidney [title]” and “carcinoid [title] and renal [title]” using the PubMed and restricted the search to articles published in English since 2013. The clinical manifestations, age, sex, tumor size, location, gross pathology, light microscopy and immunohistochemistry were analyzed. A total of 28 cases of renal carcinoid were retrieved from PubMed. Higher proportion of positive labeling of CgA, Syn, NSE and CD56 are most valuable in the diagnosis of primary renal well-differentiated neuroendocrine tumor. At present, radical nephrectomy remains the gold standard in the curative-intent therapy for well-differentiated neuroendocrine carcinoma of kidney, in metastatic renal carcinoid, long-term use of octreotide may be an effective adjuvant therapy. |
format | Online Article Text |
id | pubmed-9153994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-91539942022-06-01 Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor Jiang, Hua Zhang, He Onco Targets Ther Case Report Primary carcinoid tumor of the kidney is an extremely rare well-differentiated neuroendocrine tumor, which is generally a low-grade malignant cancer with a good prognosis. Carcinoid tumors are rarely found in the urinary system. Here, we report a 34-year-old woman with primary renal well-differentiated neuroendocrine tumor who underwent nephron sparing surgery and no evidence of recurrence or distant metastasis was found during routine follow-up. We searched the case of renal carcinoid with the search phrase “carcinoid [title] and kidney [title]” and “carcinoid [title] and renal [title]” using the PubMed and restricted the search to articles published in English since 2013. The clinical manifestations, age, sex, tumor size, location, gross pathology, light microscopy and immunohistochemistry were analyzed. A total of 28 cases of renal carcinoid were retrieved from PubMed. Higher proportion of positive labeling of CgA, Syn, NSE and CD56 are most valuable in the diagnosis of primary renal well-differentiated neuroendocrine tumor. At present, radical nephrectomy remains the gold standard in the curative-intent therapy for well-differentiated neuroendocrine carcinoma of kidney, in metastatic renal carcinoid, long-term use of octreotide may be an effective adjuvant therapy. Dove 2022-05-27 /pmc/articles/PMC9153994/ /pubmed/35655605 http://dx.doi.org/10.2147/OTT.S364545 Text en © 2022 Jiang and Zhang. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Case Report Jiang, Hua Zhang, He Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor |
title | Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor |
title_full | Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor |
title_fullStr | Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor |
title_full_unstemmed | Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor |
title_short | Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor |
title_sort | clinical and pathological features of primary renal well-differentiated neuroendocrine tumor |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153994/ https://www.ncbi.nlm.nih.gov/pubmed/35655605 http://dx.doi.org/10.2147/OTT.S364545 |
work_keys_str_mv | AT jianghua clinicalandpathologicalfeaturesofprimaryrenalwelldifferentiatedneuroendocrinetumor AT zhanghe clinicalandpathologicalfeaturesofprimaryrenalwelldifferentiatedneuroendocrinetumor |